Talphera (TLPH) Change in Accured Expenses (2010 - 2026)

Talphera's (TLPH) quarterly Change in Accured Expenses came in at -$252000.0 in Q1 2026, up 19.49% year-on-year from -$210898.4 in Q1 2025, and down 146.15% quarter-over-quarter from $546000.0 in Q4 2025.

Talphera (TLPH) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Talphera's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$252000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 19.49% year-over-year to -$252000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 428.18% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 205.11% from the prior year.
  • Change in Accured Expenses retreated to -$252000.0 in Q1 2026 per TLPH's latest filing, from $546000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $891000.0 in Q3 2025 and bottomed at -$1.5 million in Q1 2022.
  • The 5-year median for Change in Accured Expenses is -$157000.0 (2022), against an average of -$172705.9.
  • Across the five-year window, Change in Accured Expenses sank 538.57% in 2023 and surged 991.0% in 2025, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$157000.0 in 2022, then jumped by 500.64% to $629000.0 in 2023, then plunged by 161.84% to -$389000.0 in 2024, then soared by 240.36% to $546000.0 in 2025, then tumbled by 146.15% to -$252000.0 in 2026.
  • Per Business Quant, the three latest TLPH Change in Accured Expenses figures stand at -$252000.0 (Q1 2026), $546000.0 (Q4 2025), and $891000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 88.58 Bn 86.72 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn -
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -
10 Talphera 92.51 Mn 92.51 Mn - -252,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -252,000.00
Mar 31, 2026 -252,000.00
Dec 31, 2025 546,000.00
Dec 31, 2025 546,000.00
Sep 30, 2025 891,000.00
Sep 30, 2025 891,000.00
Jun 30, 2025 131,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 -313,000.00
Mar 31, 2025 -313,000.00
Dec 31, 2024 -389,000.00
Dec 31, 2024 -389,000.00
Sep 30, 2024 -100,000.00
Sep 30, 2024 -100,000.00
Jun 30, 2024 401,000.00
Jun 30, 2024 401,000.00
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 629,000.00
Dec 31, 2023 629,000.00